Pro Share Advisors LLC Bristol Myers Squibb CO Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pro Share Advisors LLC holds 316,396 shares of BMY stock, worth $17.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

316,396

Previous 338,422 6.51%

Holding current value

$17.8 Million

Previous $14.1 Million 16.5%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $873,551 - $1.14 Million	-22,026 Reduced 6.51%	316,396 $16.4 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $1.06 Million - $1.39 Million	26,267 Added 8.41%	338,422 $14.1 Million
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $361,289 - $409,632	-7,530 Reduced 2.36%	312,155 $16.9 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $181,606 - $216,706	-3,746 Reduced 1.16%	319,685 $16.4 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $936,833 - $1.05 Million	-16,183 Reduced 4.77%	323,431 $18.8 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $260,828 - $289,609	4,094 Added 1.22%	339,614 $21.7 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $2.8 Million - $3.18 Million	42,655 Added 14.56%	335,520 $23.3 Million
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $133,878 - $158,530	-1,955 Reduced 0.66%	292,865 $21.1 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $4,154 - $2.46 Million	-31,955 Reduced 9.78%	294,820 $21 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $9.92 Million - $10.9 Million	-136,568 Reduced 29.47%	326,775 $25.2 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $1.19 Million - $1.42 Million	-19,328 Reduced 4.0%	463,343 $33.8 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $3.8 Million - $4.43 Million	70,786 Added 17.19%	482,671 $30.1 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $653,946 - $766,014	-11,052 Reduced 2.61%	411,885 $24.4 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $3.69 Million - $4.02 Million	59,611 Added 16.41%	422,937 $28.3 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $750,057 - $843,593	12,640 Added 3.6%	363,326 $22.9 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $1.66 Million - $1.89 Million	28,827 Added 8.96%	350,686 $21.8 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $279,856 - $310,117	4,873 Added 1.54%	321,859 $19.4 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $1.16 Million - $1.36 Million	21,216 Added 7.17%	316,986 $18.6 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.71 Million - $11.2 Million	-166,060 Reduced 35.96%	295,770 $16.5 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $9.1 Million - $11.9 Million	184,983 Added 66.82%	461,830 $29.6 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $933,711 - $1.11 Million	21,831 Added 8.56%	276,847 $14 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $1.3 Million - $1.44 Million	-29,203 Reduced 10.27%	255,016 $11.6 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $553,848 - $660,395	12,275 Added 4.51%	284,219 $13.6 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $640,852 - $831,031	13,143 Added 5.08%	271,944 $14.1 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1.15 Million - $1.3 Million	-20,884 Reduced 7.47%	258,801 $16.1 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $843,800 - $1.05 Million	-16,699 Reduced 5.63%	279,685 $15.5 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $1.39 Million - $1.6 Million	-23,154 Reduced 7.25%	296,384 $18.7 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $4.31 Million - $4.7 Million	71,944 Added 29.06%	319,538 $19.6 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $803,154 - $926,907	14,542 Added 6.24%	247,594 $15.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	233,052	233,052 $13 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Bristol Myers Squibb CO Transaction History